Regent Pacific Group Limited (RPGLF)
OTCMKTS
· Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
At close: Jun 9, 2025
Regent Pacific Group Revenue
In the year 2024, Regent Pacific Group had annual revenue of $719.00K with 147.08% growth. Regent Pacific Group had revenue of $676.00K in the half year ending December 31, 2024, with 569.31% growth.
Revenue
719.00K
Revenue Growth
+147.08%
P/S Ratio
43.32
Revenue / Employee
47.93K
Employees
17
Market Cap
31.15M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 719.00K | 428.00K | 147.08% |
Dec 31, 2023 | 291.00K | 177.00K | 155.26% |
Dec 31, 2022 | 114.00K | -3.14M | -96.50% |
Dec 31, 2021 | 3.25M | 1.58M | 94.85% |
Dec 31, 2020 | 1.67M | 1.51M | 918.29% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.70M |